CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
57 hedge funds and large institutions have $63.3M invested in Cascadian Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 31 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
78% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 23
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
57
Holding in Top 10
–
Calls
$625K
Puts
$86K
Top Buyers
| 1 | +$530K | |
| 2 | +$468K | |
| 3 | +$362K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$332K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$147K |
Top Sellers
| 1 | -$1.31M | |
| 2 | -$1.27M | |
| 3 | -$392K | |
| 4 |
CAM
ClariVest Asset Management
San Diego,
California
|
-$370K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$189K |